MK-0916

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2011-2013
012320112013

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
AIMS To characterize pharmacokinetic parameters of MK-0916 and its safety and tolerability in lean, healthy male subjects… (More)
Is this relevant?
2013
2013
The enzyme 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) is a target for novel type 2 diabetes and obesity therapies based… (More)
Is this relevant?
Review
2013
Review
2013
OBJECTIVE Metabolic syndrome (MetS) and Cushing's syndrome share common features. It has been proposed that increased… (More)
Is this relevant?
2011
2011
AIM We examined the effects of the 11β-hydroxysteroid dehydrogenase type 1 (HSD1) inhibitor, MK-0916, on the multiple components… (More)
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2011
2011
11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) may be involved in several abnormalities associated with the metabolic… (More)
Is this relevant?